-+ 0.00%
-+ 0.00%
-+ 0.00%

Tsingke Highlights How Biotech Teams Can Evaluate and Advance Antibody Candidates at PEGS Europe 2026

Barchart·11/20/2026 08:18:00
Listen to the news

From early antibody hits to engineered formats and antibody–oligonucleotide conjugates, Tsingke helps R&D teams generate the data they need to make the next development decision.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.